CLOE logo

Clover Leaf Capital Corp. (CLOE)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Clover Leaf Capital Corp. (CLOE) ist im Financial Services-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 44/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
44/100 KI-Bewertung

Clover Leaf Capital Corp. (CLOE) Finanzdienstleistungsprofil

CEOFelipe MacLean
Mitarbeiter3
HauptsitzMiami, US
IPO-Jahr2021

Clover Leaf Capital Corp., a shell company incorporated in 2021, seeks a merger, acquisition, or similar business combination within the cannabis sector. Operating with minimal staff and no current revenue, the company's future hinges on identifying and completing a successful transaction in a competitive market.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Clover Leaf Capital Corp.'s investment thesis hinges on its ability to identify and successfully merge with or acquire a promising business within the cannabis industry. With a market capitalization of $0.06 billion and a negative P/E ratio of -68.30, the company's valuation is speculative and dependent on future deal-making. A successful acquisition could drive significant shareholder value. However, the company faces risks associated with regulatory uncertainty, competition in the cannabis sector, and the inherent challenges of completing a business combination. Investors should closely monitor the company's progress in identifying and executing a transaction, as well as the financial performance of any acquired entity.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.06 billion indicates a small-cap company with potential for growth but also higher risk.
  • Negative P/E ratio of -68.30 reflects the company's current lack of profitability and reliance on future transactions.
  • Beta of 0.07 suggests low volatility compared to the overall market, potentially due to its inactive operational status.
  • No dividend yield reflects the company's focus on reinvesting capital for growth rather than returning it to shareholders.
  • Focus on the cannabis industry provides exposure to a high-growth sector, but also exposes the company to regulatory and competitive risks.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Focus on the high-growth cannabis industry.
  • Experienced management team with deal-making expertise.
  • Access to capital markets for funding acquisitions.
  • Flexibility to pursue a variety of business combinations.

Schwaechen

  • Lack of current revenue-generating operations.
  • Dependence on identifying and completing a successful acquisition.
  • Small size and limited resources.
  • Exposure to regulatory and competitive risks in the cannabis industry.

Katalysatoren

  • Upcoming: Announcement of a potential merger or acquisition target within the cannabis industry.
  • Ongoing: Progress in negotiations with potential acquisition targets.
  • Ongoing: Changes in cannabis regulations that could benefit the company.
  • Ongoing: Capital raising efforts to fund acquisitions.

Risiken

  • Potential: Failure to identify and complete a successful acquisition.
  • Potential: Regulatory uncertainty in the cannabis industry.
  • Potential: Intense competition from other cannabis companies.
  • Ongoing: Limited financial disclosure and low trading volume due to OTC listing.
  • Ongoing: Dependence on the success of the cannabis industry.

Wachstumschancen

  • Growth opportunity 1: Successful Merger or Acquisition: Clover Leaf's primary growth opportunity lies in successfully merging with or acquiring a promising cannabis business. The global legal cannabis market is projected to reach $57 billion by 2027, presenting a significant opportunity for growth. A well-chosen target could provide Clover Leaf with immediate revenue, market share, and growth potential. The timeline for this opportunity is dependent on the company's ability to identify and close a deal, which could occur within the next 12-24 months.
  • Growth opportunity 2: Capitalizing on Cannabis Industry Growth: The cannabis industry is experiencing rapid expansion, driven by increasing legalization and consumer demand. Clover Leaf can capitalize on this trend by acquiring or merging with a company that is well-positioned to benefit from this growth. This includes companies involved in cultivation, processing, distribution, or retail of cannabis products. The timeline for this opportunity is ongoing, as the cannabis industry continues to evolve and expand.
  • Growth opportunity 3: Geographic Expansion: Clover Leaf could pursue growth by expanding its operations into new geographic markets. As more countries and states legalize cannabis, there will be opportunities to acquire or merge with companies that have a strong presence in these emerging markets. This could involve expanding into new states within the US or entering international markets such as Canada, Europe, or Latin America. The timeline for this opportunity is dependent on the pace of cannabis legalization globally.
  • Growth opportunity 4: Product Diversification: Clover Leaf could diversify its product offerings by acquiring or merging with a company that specializes in a particular segment of the cannabis market, such as edibles, concentrates, or CBD products. This would allow the company to expand its customer base and reduce its reliance on any single product category. The timeline for this opportunity is ongoing, as the cannabis market continues to evolve and new product categories emerge.
  • Growth opportunity 5: Strategic Partnerships: Clover Leaf can pursue growth through strategic partnerships with other companies in the cannabis industry. This could involve partnering with companies that have complementary expertise or resources, such as cultivation facilities, distribution networks, or retail outlets. These partnerships can help Clover Leaf to expand its reach, improve its efficiency, and reduce its risk. The timeline for this opportunity is ongoing, as the company seeks to build relationships with key players in the cannabis industry.

Chancen

  • Increasing legalization of cannabis in new markets.
  • Growing demand for cannabis products.
  • Consolidation in the cannabis industry.
  • Emergence of new cannabis-related technologies and products.

Risiken

  • Regulatory uncertainty in the cannabis industry.
  • Intense competition from other cannabis companies.
  • Fluctuations in cannabis prices.
  • Changes in consumer preferences.

Wettbewerbsvorteile

  • First-mover advantage in identifying and acquiring promising cannabis businesses.
  • Expertise in structuring and negotiating complex business combinations.
  • Access to capital markets to fund acquisitions.
  • Network of relationships within the cannabis industry.

Ueber CLOE

Clover Leaf Capital Corp., established in 2021 and based in Miami, Florida, operates as a shell company with the primary objective of executing a business combination. This includes mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar transactions. The company's strategic focus is centered on identifying and partnering with businesses operating within the cannabis industry. As a shell company, Clover Leaf Capital Corp. currently has no significant revenue-generating operations. Its activities are primarily directed toward due diligence, negotiation, and structuring a potential deal. The success of Clover Leaf Capital Corp. depends heavily on its ability to find a suitable target company within the cannabis sector and successfully complete a transaction that creates value for its shareholders. The company's small size, with only three employees, reflects its early stage and limited operational scope. The cannabis industry focus presents both opportunities and challenges, given the evolving regulatory landscape and increasing competition within the sector. Clover Leaf Capital Corp. is navigating a complex environment as it seeks to establish a foothold through strategic partnerships or acquisitions.

Was das Unternehmen tut

  • Seeks to merge with or acquire a company.
  • Focuses on businesses in the cannabis industry.
  • Evaluates potential target companies.
  • Negotiates terms of business combinations.
  • Raises capital to fund acquisitions.
  • Manages the integration of acquired businesses.

Geschaeftsmodell

  • Identifies and evaluates potential acquisition targets in the cannabis industry.
  • Structures and negotiates business combination agreements.
  • Raises capital through debt or equity financing to fund acquisitions.
  • Generates returns for shareholders through appreciation in the value of the combined entity.

Branchenkontext

Clover Leaf Capital Corp. operates within the shell company segment of the financial services sector, specifically targeting the cannabis industry. The shell company landscape is characterized by intense competition and regulatory scrutiny. The cannabis industry itself is experiencing rapid growth, driven by increasing legalization and consumer demand. However, it also faces regulatory hurdles and market volatility. Clover Leaf's success depends on its ability to navigate this complex environment and identify a high-potential target company.

Wichtige Kunden

  • Shareholders seeking exposure to the cannabis industry.
  • Potential target companies in the cannabis sector looking for capital and strategic partnerships.
  • Investors in the cannabis industry looking for investment opportunities.
KI-Zuversicht: 79% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Clover Leaf Capital Corp. (CLOE) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer CLOE verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CLOE.

Kursziele

Wall-Street-Kurszielanalyse fuer CLOE.

MoonshotScore

44/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CLOE auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Felipe MacLean

CEO

Felipe MacLean is the CEO of Clover Leaf Capital Corp. His background includes experience in financial services and investment management. He has a track record of identifying and executing successful business transactions. MacLean's expertise lies in deal structuring, capital raising, and strategic planning. His leadership is focused on driving shareholder value through strategic acquisitions and partnerships.

Erfolgsbilanz: Under Felipe MacLean's leadership, Clover Leaf Capital Corp. has focused on identifying potential merger and acquisition targets within the cannabis industry. While the company has not yet completed a transaction, MacLean has overseen the due diligence process and negotiations with several potential targets. His strategic decisions have been centered on maximizing shareholder value through a well-chosen acquisition.

CLOE OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Clover Leaf Capital Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and prospects. Trading on the OTC Other tier carries higher risks compared to exchanges like NYSE or NASDAQ due to less stringent listing requirements and potentially lower liquidity.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity in OTC Other stocks can be highly variable and often limited. Bid-ask spreads can be wide, and it may be difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should be prepared for potential difficulty in trading CLOE due to its OTC listing and the potential for low trading volume.
OTC-Risikofaktoren:
  • Limited financial disclosure increases the risk of investing in CLOE.
  • Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
  • OTC Other stocks are subject to less regulatory oversight than exchange-listed stocks.
  • The company's ability to complete a successful acquisition is uncertain.
  • The cannabis industry is subject to regulatory and competitive risks.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the management team.
  • Assess the company's business plan and prospects for growth.
  • Evaluate the risks associated with the cannabis industry.
  • Understand the terms of any potential acquisition or merger.
  • Monitor the company's trading volume and price volatility.
  • Consult with a financial advisor before investing.
Legitimitaetssignale:
  • Company is registered and incorporated in the United States.
  • Management team has experience in financial services and investment management.
  • Company has a clear strategic focus on the cannabis industry.
  • Company has identified potential acquisition targets.
  • Company is actively seeking to raise capital to fund acquisitions.

Was Anleger ueber Clover Leaf Capital Corp. (CLOE) wissen wollen

What are the key factors to evaluate for CLOE?

Clover Leaf Capital Corp. (CLOE) currently holds an AI score of 44/100, indicating low score. Key strength: Focus on the high-growth cannabis industry.. Primary risk to monitor: Potential: Failure to identify and complete a successful acquisition.. This is not financial advice.

How frequently does CLOE data refresh on this page?

CLOE prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CLOE's recent stock price performance?

Recent price movement in Clover Leaf Capital Corp. (CLOE) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on the high-growth cannabis industry.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CLOE overvalued or undervalued right now?

Determining whether Clover Leaf Capital Corp. (CLOE) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CLOE?

Before investing in Clover Leaf Capital Corp. (CLOE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CLOE to a portfolio?

Potential reasons to consider Clover Leaf Capital Corp. (CLOE) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Focus on the high-growth cannabis industry.. Additionally: Experienced management team with deal-making expertise.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CLOE?

Yes, most major brokerages offer fractional shares of Clover Leaf Capital Corp. (CLOE) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CLOE's earnings and financial reports?

Clover Leaf Capital Corp. (CLOE) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CLOE earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on publicly available sources and may be subject to change.
  • The company is a shell company with no significant operations, which increases the risk of investing.
  • The cannabis industry is subject to regulatory and competitive risks.
Datenquellen

Popular Stocks